SOX9 and osteosarcoma: Likewise, SOX9 expression was shown to drive mesenchymal proliferation and extracellular matrix remodeling in chordoma and osteosarcoma models, while GATA4 has recently been linked to myogenic reprogramming and mesodermal lineage persistence [19,20].